Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation

Childhood pneumococcal conjugate vaccine (PCV) protects against invasive pneumococcal disease caused by vaccine-serotype (VT) Streptococcus pneumoniae by generating opsonophagocytic anti-capsular antibodies, but how vaccination protects against and reduces VT carriage is less well understood. Using...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolf, Asia-Sophia, Mitsi, Elena, Jones, Scott, Jochems, Simon P., Roalfe, Lucy, Thindwa, Deus, Meiring, James E., Msefula, Jacquline, Bonomali, Farouck, Makhaza Jere, Tikhala, Mbewe, Maurice, Collins, Andrea M., Gordon, Stephen B., Gordon, Melita A., Ferreira, Daniela M., French, Neil, Goldblatt, David, Heyderman, Robert S., Swarthout, Todd D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615833/
https://www.ncbi.nlm.nih.gov/pubmed/36210249
http://dx.doi.org/10.1016/j.vaccine.2022.09.069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615833/
https://www.ncbi.nlm.nih.gov/pubmed/36210249
http://dx.doi.org/10.1016/j.vaccine.2022.09.069

Ejemplares similares